DavidAltonBellMD

PubMed

• A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators.
  Angus DC, Barnato AE, Bell D, Bellomo R, Chong C, Coats TJ, Davies A, Delaney A, Harrison DA, Holdgate A, Howe B, Huang DT, Iwashyna T, Kellum JA, Peake SL, Pike F, Re...> ;Intensive Care Med. 2015-09-01
• Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: results from the Canadian Upper Tract Collaboration.
  Fradet V, Mauermann J, Kassouf W, Rendon R, Jacobsen N, Fairey A, Izawa J, Kapoor A, Black P, Tanguay S, Chin J, So A, Lattouf J, Bell D, Saad F, Sheyegan B, Drachenbe...> ;Urol. Oncol.. 2014-08-01
• 27 citations
  Effect of body mass index on the outcomes of patients with upper and lower urinary tract cancers treated by radical surgery: Results from a Canadian multicenter collab...
  Bassel G. Bachir, Armen Aprikian, Jonathan I. Izawa, Joseph L. Chin, Yves Fradet, Adrian Fairey, Eric Estey, Niels Jacobsen, Ricardo A. Rendon, Ilias Cagiannos, Louis ...> ;Urologic Oncology. 2014 May 1
• Antihomocitrullinated Fibrinogen Antibodies are Specific to Rheumatoid Arthritis and Frequently Bind Citrullinated Proteins/peptides.
  Scinocca, M.,Bell, D. A.,Racapé, M.,Joseph, R.,Shaw, G.,McCormick, J. K.,Gladman, D. D.,Pope, J.,Barra, L.,Cairns, E.> ;J. Rheumatol.. 2014 Jan 17
• Negative regulation of the peptidylarginine deiminase type IV promoter by NF-κB in human myeloid cells.
  Abbas AK, Le K, Pimmett VL, Bell DA, Cairns E, Dekoter RP> ;Gene. 2014-01-01
• Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome.
  Yafi FA, Tanguay S, Rendon R, Jacobsen N, Fairey A, Izawa J, Kapoor A, Black P, Lacombe L, Chin J, So A, Lattouf J, Bell D, Fradet Y, Saad F, Matsumoto E, Drachenberg ...> ;Urol. Oncol.. 2014-01-01
• Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration.
  Fairey AS, Kassouf W, Estey E, Tanguay S, Rendon R, Bell D, Izawa J, Chin J, Kapoor A, Matsumoto E, Black P, So A, Lattouf J, Saad F, Drachenberg D, Cagiannos I, Lacom...> ;BJU Int.. 2013-10-01
• Comorbidity status does not independently predict survival outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
  Fairey AS, Jacobsen N, Estey E, Tanguay S, Rendon R, Bell D, Izawa J, Chin J, Kapoor A, Matsumoto E, Black P, So A, Lattouf J, Saad F, Drachenberg D, Cagiannos I, Laco...> ;Eur. Urol.. 2013-09-01
• Regional differences in practice patterns and outcomes in patients treated with radical cystectomy in a universal healthcare system.
  Bachir BG, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagiannos I, Lacombe L, Lattouf J, Bell D, Saad F, Drachenberg D, Kassouf W> ;Can Urol Assoc J. 2013-01-01
• Natural history of pT3-4 or node positive bladder cancer treated with radical cystectomy and no neoadjuvant chemotherapy in a contemporary North-American multi-institu...
  Power NE, Kassouf W, Bell D, Aprikian AG, Fradet Y, Lacombe L, Chin J, Izawa J, Estey E, Fairey A, Cagiannos I, Lattouf J, Drachenberg D, Rendon RA> ;Can Urol Assoc J. 2012-12-01
• Outcomes of pT0N0 at radical cystectomy: The Canadian Bladder Cancer Network experience.
  Sandhu GS, Aprikian A, Chin J, Fradet Y, Izawa J, Estey E, Fairey A, Rendon R, Cagiannos I, Lacombe L, Lattouf J, Bell D, Kassouf W, Drachenberg D> ;Can Urol Assoc J. 2012-06-01
• Immunisation with Porphyromonas gingivalis enolase induces autoimmunity to mammalian ?-enolase and arthritis in DR4-IE transgenic mice.
  Kinloch, A.J., Alzabin, S., Brintnell, W., Wilson, E., Barra, L., Wegner, N., Bell, D.A., Cairns, E., Venables, P.J.> ;Arthritis Rheum. 2011 Dec
• CTLA-4Ig blocks the development and progression of citrullinated fibrinogen-induced arthritis in DR4-transgenic mice.
  Yue, D., Brintnell, W., Mannik, L.A., Christie, D.A., Haeryfar, S.M., Madrenas, J., Chakrabarti, S., Bell, D.A., Cairns, E.> ;Arthritis Rheum. 2010 Oct
• Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis.
  Ercan, A., Cui, J., Chatterton, D.W., Deane, K.D., Hazen, M.M., Brintnell, W., O'Donnell, C.I., Derber, L.A., Weinblatt, M.E., Shadick, N.A., Bell, D.A., Cairns, E., S...> ;Arthritis Rheum. 2010 Aug
• An intriguing relationship between the immune response to citrullinated vimentin and the HLA shared epitope: comment on the article by Verpoort et al.
  Bell, D.A., Hill, J.A., Cairns, E.> ;Arthritis Rheum. 2008-10-01
• Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice.
  Hill, J.A., Bell, D.A., Brintnell, W., Yue, D., Wehrli, B., Jevnikar, A.M., Lee, D.M., Hueber, W., Robinson, W.H., Cairns, E.> ;J Exp Med. 2008 Apr 14
• Intermedin (adrenomedullin-2): a novel counter-regulatory peptide in the cardiovascular and renal systems.
  Bell D, McDermott BJ> ;Br. J. Pharmacol.. 2008-03-01
• SRIF receptor subtype expression and involvement in positive and negative contractile effects of somatostatin-14 (SRIF-14) in ventricular cardiomyocytes.
  Bell D, Zhao Y, McMaster B, McHenry EM, Wang X, Kelso EJ, McDermott BJ> ;Cell. Physiol. Biochem.. 2008-01-01
• Expression of the counter-regulatory peptide intermedin is augmented in the presence of oxidative stress in hypertrophied cardiomyocytes.
  Bell D, Zhao Y, McCoy FPG, Devine A, McDermott BJ> ;Cell. Physiol. Biochem.. 2008-01-01
• Influence of atenolol and nifedipine on nitric-oxide deficient cardiomyocyte hypertrophy and expression of the cardio-endocrine peptide intermedin and its receptor com...
  Bell D, Zhao YY, Devine AB, McDermott BJ> ;Cell. Physiol. Biochem.. 2008-01-01
• Invasive Cryptococcus neoformans infection in an asplenic patient.
  Qazzafi Z, Thiruchunapalli D, Birkenhead D, Bell D, Sandoe JAT> ;J. Infect.. 2007-12-01
• The influence of MHC class II molecules containing the rheumatoid arthritis shared epitope on the immune response to aggrecan G1 and its peptides.
  Brintnell W, Bell DA, Hill JA, Jevnikar AM, Sette A, Sidney J, Doege K, Cairns E> ;Scand. J. Immunol.. 2007-05-01
• Protection of cardiomyocyte function by propofol during simulated ischemia is associated with a direct action to reduce pro-oxidant activity.
  McDermott BJ, McWilliams S, Smyth K, Kelso EJ, Spiers JP, Zhao Y, Bell D, Mirakhur RK> ;J. Mol. Cell. Cardiol.. 2007-03-01
• NPY and cardiac diseases.
  McDermott BJ, Bell D> ;Curr Top Med Chem. 2007-01-01
• Differential effects of an anti-oxidant intervention on cardiomyocyte expression of adrenomedullin and intermedin and their receptor components in chronic nitric oxide...
  Bell D, Zhao Y, McCoy FPG, Devine AB, McDermott BJ> ;Cell. Physiol. Biochem.. 2007-01-01
• Join now to see all